ArticleArchives of sexual behavior2026
Considerations of HIV PrEP Among Heterosexually Active Women and Men: Results from a Qualitative Study in New York City.
Article in Archives of sexual behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Although 22% of new HIV diagnoses in the USA are attributed to heterosexual contact, uptake of pre-exposure prophylaxis (PrEP) remains low among heterosexually active individuals and information about PrEP considerations in this population is limited. We report on a cross-sectional qualitative study exploring attitudes toward PrEP among a diverse sample of 50 heterosexually active cisgender adults (31 women, 19 men) in New York City. Approximately, two-thirds (34) had previously heard of PrEP, but none had used it. Many learned about PrEP through marketing and social interactions, leading them to perceive it as primarily intended for gay or bisexual men and transgender individuals. Most had never discussed PrEP or received information about it in healthcare settings, despite recent HIV screenings. Participants generally viewed PrEP as irrelevant because they perceived themselves at low risk for HIV, considering it appropriate only for people with many sex partners or partners with HIV. Some said they would view a potential partner using PrEP positively (e.g., as responsible), while others expressed concerns about their presumed behaviors. Concerns about side effects and long-term drug toxicity were common and a few participants expressed anti-medication beliefs. While awareness appears high, heterosexually active New Yorkers do not seem to have started to think of PrEP as one of their HIV prevention options. PrEP promotion for this population could benefit from: messaging targeted to heterosexual adults; ensuring health-care providers inform all sexually active patients about PrEP; and clarifying for practitioners and the public that PrEP is an option for any sexually active person, regardless of self-reported HIV risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.